Alexis Gilroy advises health care and technology companies on health care/corporate matters emphasizing digital health topics (telemedicine, telehealth, and mobile health). She counsels and directs transactions involving venture capital, private equity, debt financing, joint ventures, mergers, acquisitions, management arrangements, physician engagement, strategic alliances, hospital affiliation, and general/complex contractual needs, including cross-border transactions.
Alexis has broad experience with practical/legal needs of health care companies in the evolving global health care market, especially unique legal issues faced by e-health companies. Prior to joining Jones Day, she managed more than 20 strategic M&A transactions for a publicly traded health care company involving cyberknife, imaging centers, teleradiology companies, and radiation oncology centers. She advises investors and companies on multijurisdictional business strategy and implementation matters specific to e-health programs, business models, devices, and products and has counseled on regulations regarding e-consults, online prescribing, patient consents, credentialing by proxy, corporate practice of medicine, physician supervision, reimbursement, anti-kickback, and licensure matters specific to e-health providers and businesses; developed and negotiated e-health specific customer, vendor, and affiliation contracts and documentation; structured research arrangements involving HIT (health information technology); and led strategy and communications with medical boards and other regulators and policy makers on e-health matters.
Alexis speaks extensively on matters involving digital health, including testimony before legislative and regulatory bodies. She serves on the board of directors of the American Telemedicine Association and as appointee to the Maryland Governor’s Telemedicine Taskforce, member of the Federation of State Medical Boards’ workgroup on telehealth, and leader of the American Health Lawyer Association’s E-Health and Telemedicine Affinity Group.